Printer Friendly

Evaluation of DNA binding, cleavage, and cytotoxic activity of Cu(II), Co(II), and Ni(II) Schiff base complexes of 1-phenylindoline-2,3-dione with Isonicotinohydrazide.

1. Introduction

Isatin(1-H indole-2,3-dione) Schiff bases are significant in therapeutic and pharmaceutical compounds in the field [1]. These complexes also exhibited their wide antibacterial [2], antifungal [3], and antitumor activity [4, 5]. Nitrogen containing heterocyclic compounds are identified as indispensable structural units for both the chemists and biochemists [6, 7]. Among the various classes of benzene fused five-membered nitrogen containing heterocyclic compounds, isatin derivatives could be used pharmacologically as an important class of active components [8-10]. The interactions of Schiff base metal complexes containing O and N coordination with DNA have been thoroughly considered [11, 12]. Recently, there has been remarkable interest in studies related to the interaction of transition metal ions with nucleic acid because of their relevance in the development of new reagents for biotechnology and medicine [13]. These studies are also essential to understand the toxicity of drugs containing metal ions [14]. Transition metal complexes have gained significance for their applicability in the biological field [15, 16]. Some of the transition metal complexes, such as Cu(II), were known to function as specific probe for DNA bulges due its ability to cleave DNA [17]. Recently, we have reported our results on the interaction of bidentate Schiff base complexes with DNA [18,19]. In this background, this study highlights the binding, cleavage, and cytotoxicity with the new series of transition metals N-phenylisatin-isonicotinohydrazide Schiff base complexes with calf thymus DNA and AGS cell line, respectively.

2. Experimental

2.1. Materials. All chemicals were purchased from Sigma-Aldrich, Merck-(A.R) and used as received without further purification. The isatin Schiff base was prepared according to the literature procedure [20]. N-phenylisatin, isonicotino-hydrazide, and DMSO are GR grade; CT and pUC-19 DNA were purchased from Genie, Bangalore. Metal chlorides [Cu[Cl.sub.2]-2[H.sub.2]O, Ni[Cl.sub.2]-6[H.sub.2]O, Co[Cl.sub.2]-6[H.sub.2]O] and solvents were purchased from E-Merck, A.R grade, Mumbai.

2.2. Physical Measurements. C, H, and N analyses of free Schiffbase ligands and their metal complexes were performed in C, H, and N analyzer Elementar Vario EL III. Metal contents were analyzed by the standard procedures. Hand-Held Meter LF330 was used to measure the molar conductance of free Schiff base ligands and metal complexes in DMSO (1 x [10.sup.-3] M). The electronic spectra were recorded in DMSO solutions using Shimatzu Model 160 UV-visible spectrophotometer. The IR spectra of the complexes were recorded on a JASCO V-550 UV-Vis spectrophotometer in KBr pellets. NMR spectra were recorded on BRUKER DPX300 High performance Digital FT-NMR spectrometer in DMSO-[d.sup.6] using TMS as internal standard. Electrospray ionisation mass spectrometry (ESI-MS) analysis was performed in the positive ion mode on a liquid chromatography-ion trap mass spectrometer (LCQ Fleet), Thermo Fisher Instruments Limited, US. Magnetic susceptibility measurement of the powdered samples was carried out by the Gouy balance. EPR measurements were carried out by using a Varian E4 Xband spectrometer equipped with 100 Hz modulation. Cyclic Voltammetric measurements were carried out in a BioAnalytical System (BAS) model CV-50W electrochemical analyzer.

2.3. DNA Binding and Cleavage

2.3.1. Electronic Absorption Studies. DNA-binding experiments were performed by UV-visible spectroscopy in TrisHCl/NaCl buffer (5 mmol [L.sup.-1] Tris-HCl/50mmol[L.SUP.-1] NaCl buffer, pH 7.2) and used DMSO (10%) solution of metal complexes. The concentration of CT-DNA was determined from the absorption intensity at 260 nm with a value of 6600 [(mol[L.SUP.-1]).sup.-1] [cm.sup.-1]. Absorption titration experiments were made using different concentrations of CT-DNA, while keeping the complex concentration constant. Correction was made for the absorbance of the CT-DNA itself. Samples were equilibrated before recording each spectrum. For metal complexes, the intrinsic binding constant ([K.sub.b]) was determined from the spectral titration data using the following equation [21]:

[DNA]/([[epsilon].sub.a] - [[epsilon].sub.f]) = [DNA]/([[epsilon].sub.b] - [[epsilon].sub.f]) + 1/[K.sub.b]([[epsilon].sub.b] - [[epsilon].sub.f]), (1)

where [[epsilon].sub.a], [[epsilon].sub.b], and [[epsilon].sub.f] are the molar extinction coefficients of the free complexes in solution, complex in the fully bound from with CT-DNA, and complex bound to DNA at a definite concentration, respectively. In the plot of [DNA]/([[epsilon].sub.a] - [[epsilon].sub.f]) versus [DNA], [K.sub.b] was calculated.

2.3.2. Circular Dichroism (Cd) Measurements. Circular dichroism spectra were registered in a JASCO J-810 spectropolarimeter, using a quartz cuvette of 0.2 cm path length, at room temperature, in the range 230-330 nm. The initial experimental DNA concentration was 800 [micro]M, and the spectra were registered in the absence or in the presence of 10 to 50 [micro]M of each complex studied 22].

2.3.3. Electrochemical Studies. Cyclic voltammetry analysis was carried out in a Bio-Analytical System (BAS) model CV-50W electrochemical analyzer. All voltammetric experiments were performed in a single compartment cell of volume 10-15 mL containing a three electrode system comprising a carbon working electrode, Pt-wire as auxiliary electrode, and reference electrode as an Ag/AgCl.

2.3.4. DNA Cleavage Studies. pUC19 DNA at pH 7.5 in Tris-HCL buffered solution was used to perform Agarose gel electrophoresis. Oxidative cleavage of DNA was examined by keeping the concentration of the 30 [micro]M of complexes and 2 [micro]L of pUC19 DNA and this made up the volume to 16 [micro]L with 5 mM Tris-HCl/5 mM NaCl buffer solution. The resulting solutions were incubated at 37[degrees] C for 2h and electrophoresed for 2 h at 50 V in Tris-acetate-EDTA (TAE) buffer using 1% Agarose gel containing 1.0 [micro]g/mL ethidium bromide and photographed under UV light [23].

2.4. Cytotoxicity. Cytotoxicity studies were carried out using human gastric cancer cell line (designated AGS) which were obtained from National Centre for Cell Science (NCCS), Pune, India. Cell viability was carried out using the MTT assay method. The AGS cells were grown in Dulbecco's Modified Eagle's Medium (DME) and Ham's F-12 Nutrient Mixture containing 10% fetal bovine serum (FBS), 1% Glutamine, 1% antibiotic, 1% sodium bicarbonate, and 1% nonessential amino acids. For screening experiment, AGS cells were seeded into 96-well plates in 100 [micro]L of respective medium containing 10% FBS, at plating density of 10,000 cells/well and incubated at 37[degrees]C, 5% [Co.sub.2] for 24 h prior to addition of complexes. The complexes were dissolved in DMSO and diluted in the medium. After 24 h, the medium was replaced with respective medium containing the complexes at various concentrations and incubated at 37[degrees]C, 5% [Co.sub.2] for 48 h. Triplicate was maintained. After 48 h, 10 [micro]L of MTT (5 mg/mL) in phosphate buffered saline (PBS) was added to each well and incubated at 37[degrees]C for 4h. The medium with MTT was then flicked off and the formed formazan crystals were dissolved in 100 [micro]L of DMSO and then measured the absorbance at 570 nm using microplate reader. The percentage of cell inhibition was determined using the following formula and chart was plotted between percentage of cell inhibition and concentration, and from this I[C.sub.50] value was calculated. percentage of inhibition = [mean OD of untreated cells (control)/mean OD of treated cells (control)] x 100 [24].

2.5. Chemistry of the Synthesis Compounds

2.5.1. Synthesis of (E)-N'-(2-Oxo-1-phenylindolin-3-lidene) Isonicotinohydrazide (L). 1-Phenyl isatin (1 mMol) and isonicotinohydrazide (1 mMol) were dissolved in 50 mL of absolute ethanol; three drops of glacial acetic acid were added and the resulting solution was refluxed for 5h. The results compounds were precipitated upon cooling to room temperature, isolated by filtration, and recrystallized from EtOH. Yellow colored crystalline compounds were obtained (Scheme 1). These ligands were confirmed by Elemental analyzer, IR, NMR, and Mass spectra. Yield: 95%, m.p. 180[degrees]C, elemental analysis: found (calculated) (%) for L: C, 70.01 (70.14); H, 3.97 (4.12); N, 16.52 (16.37). IR ([cm.sup.-1] in KBr pellets): 1602 (C=N), 1695 (indole-C=O), 1685 (C=O, isoniazid), 3269 (NH). [sup.1]H NMR (300 MHz, CD[Cl.sub.3], [delta]/ppm): [delta] 14.21 (s, 1H), [delta] 8.80-8.78 (d, pyridine protons, 4H), 7.93-6.86 (m, aromatic protons); [sup.13]C-NMR 162.15 (C=O, isatin), 161.81 (C=O, isoniazid), 134.55 (C=N, azomethine carbon), 150.91-110.12 (aromatic ring) ESI-MS = 343 (M+H).

2.5.2. Synthesis of Cu(II), Co(II), and Ni(II) Complexes. The metal(II) complexes in this study were prepared by mixing of 1 mMol of corresponding metal(II) chloride in ethanol with 2mM of the Schiff base in the molar ratio 1:2. The reaction mixture was refluxed at 60[degrees]C for 4hrs [25]. Then it was allowed to cool at room temperature. Powdered solid obtained was filtered, washed with ethanol, and dried under vacuum (Scheme 2). The Schiff base complexes were characterized by elemental analysis, UV-visible, infrared (IR), electron paramagnetic resonance (EPR) spectroscopy, and magnetic moment.

Complex 1. Yield: 83%, m.p. > 300[degrees]C, elemental analysis: found (calculated) (%) for L-Cu: C, 59.37 (59.03); H, 3.71 (3.75); N, 13.11 (13.43). UV-visible (in MeOH): [[lambda].sub.max] (nm): 278(ILCT), 344(ILCT), 454(MLCT), 810(d-d). IR ([cm.sup.-1]): 1612 (C=N), 1691 (indole-C=O), 1673 (-NH-C=o), 3265 (NH), 601 (M-O), 453 (M-N), [g.sub.[parallel]] = 2.339; [g.sub.[perpendicular to]] = 2.05; [A.sub.[parallel]] = 120 x [10.sup.4], [[mu].sub.eff] (300K):2.95[[mu].sub.b].

Complex 2. Yield: 80%. m.p. > 285[degrees]C elemental analysis: found (calculated) (%) for L-Co: C, 59.32 (59.36); H, 3.63 (3.77) ; N, 13.47 (13.51). UV-visible (in DMSO): [[lambda].sub.max] (nm): 276(ILCT), 344(ILCT), 612, 674 (d-d). IR ([cm.sup.-1]): 1612 (C=N), 1693 (indole-C=O), 1676(-NH-C=O), 3263(NH), 572(M-O), 447 (M-N), [[mu].sub.eff] (300 K): 4.52 [[mu].sub.B].

Complex 3. Yield: 80%. m.p. > 285[degrees]C, elemental analysis: found (calculated) (%) for L-Ni: C, 59.35(59.38); H, 3.68 (3.77); N, 13.56 (13.51). UV-visible (in DMSO): [[lambda].sub.max] (nm): 274(ILCT), 344(ILCT), 452(MLCT). IR ([cm.sup.-1]): 1610(C=N), 1693 (indole-C=O), 1674 (-NH-C=O), 3268(NH), 574(MO), 449 (M-N), [[mu].sub.eff] (300 K): 3.41 [[mu].sub.B].

3. Results and Discussion

The Schiff base ligand (L) and their complexes with Cu(II), Co(II), and Ni(II) were found to be air stable, amorphous, moisture free, and soluble only in DMF and DMSO solvents and kept in vacuum desiccators under nitrogen atmosphere and used for chemical and biological studies. The experimental results are discussed under various subheadings as detailed below.

3.1. Elemental Analysis and Conductivity Measurements. Physicochemical characteristics such as melting point (m.p.), color, yield, elemental analysis, and conductivity of the ligand(L) and complexes were determined and the data shown in Table 1. The observed low conductivity values (22.038.40 [[OMEGA].sup.-1] [cm.sup.2] mo[L.sup.-1]) were accounted for the dissociation and hence the complexes are found as nonelectrolytes [26].

3.2. NMR Spectra. The [sup.1]H-NMR (300 MHz, CD[Cl.sub.3], [delta]/ppm) spectrum of the Schiff base which exhibited a signal at 14.21(s, 1H) was assigned to the NH proton of isonicotinohydrazide and the signals at 7.93-6.86 (m, 13H) were assigned to aromatic protons (Figure 1(a)). The [sup.13]CNMR spectra provide further support for the structure evidence of the ligand. The signals at 162.15 and 161.81 confirm the carbonyl carbon of isatin and isonicotinohydrazide. The signals appeared at 134.55; it confirms the formation of imine carbon and signals from 150.91 to 110.12, the aromatic rings (Figure 1(b)).

3.3. Analysis of Mass Spectra. Mass spectrometry (MS) an analytical technique that measures the mass-to-charge ratio of charged particles. ESI mass spectra for ligand and complexes were recorded and are shown in Figure 2. MS[ESI (M+1)] exact mass calculated for L (a) required m/z 342.81 and found m/z 343.96 and copper(II) (b) complex required m/z 819.9 and found m/z 820. These values also confirm the formation of ligand and complexes.

3.4. Infrared Spectra. In order to study the bonding mode of ligand moiety to metal ion in the complexes, IR spectra of the free ligand were compared with those of the metal complexes. The FT-IR spectral data are summarized in Table 2. The IR spectrum of the free ligand (L) showed broadband at 3269 [cm.sup.-1], which can be attributed to NH stretching vibration of the isoniazid structural unit. The position of these bands remained at nearly the same frequency in the spectra of the metal complexes which suggests the noncoordination of this group to central metal ion in the metal complexes [27]. A sharp peak at 1602 [cm.sup.-1] was assigned to [nu](C=N), which is characteristic of Schiff bases. In the spectra of the complexes, this peak is slightly shifted to higher frequency around 16101612 [cm.sup.-1]. This suggested that one point of attachment of the metal is through the azomethine nitrogen atom [28, 29]. The strong intensity bands of ligand were observed at the region 1685 [cm.sup.-1] of the spectra indicating carbonyl group. The position of these bands was shifted to lower region 1673-1676 [cm.sup.-1], indicating the involvement of [nu](C=O) with metal centre during complexation. The bands at 1695 [cm.sup.-1] and 1691-1693 [cm.sup.-1] in the spectrum of the free ligand and complexes, respectively, were assigned to [nu](C=O) of isatin moiety. The positions of these bands were found at nearly the same frequency in spectra of the metal complexes, suggesting the uncoordination of this group. New bands observed in the 447-453 and 572-601 [cm.sup.-1] for the complexes were assigned to stretching frequencies of M-N and M-O, respectively [30, 31]. Thus, the IR spectral results provide evidence for bidentate complex formation of Schiff bases with metals.

3.5. Electronic Spectra and Magnetic Moment Values. The electronic spectra of the ligand and its Cu(II), Co(II), and Ni(II) complexes were recorded in DMSO and their probable assignments are given in Table 3. The absorption bands at 36764 [cm.sup.-1] and 29239 [cm.sup.-1] attributed to [pi] [right arrow] [[pi].sup.*] and n [right arrow] [[pi].sup.*] transitions in the ligand(L). The Cu(II) complex showed d-d band at 12345 [cm.sup.-1]. These bands maybe assigned to [sup.2][B.sub.1g] [right arrow] [sup.2][B.sub.2g], [sup.2][E.sub.g] transitions. The position of these bands is consistent with octahedral geometry around the Cu(II) ion. The electronic spectra of Co(II) complex exhibited the absorption d-d bands at 16339 and 14836 [cm.sup.-1]. These bands may be assigned to [sup.4][T.sub.1g](F) [right arrow] [sup.4][T.sub.1g](P) and [sup.4][T.sub.1g](F) [right arrow] [sup.4][A.sub.2g] transitions. The position of these bands is consistent with octahedral geometry around the Co(II) ion. The Cu(II) and Co(II) complexes showed paramagnetism, 4.52 and 4.13 BM respectively [32, 33]. Similarly, the electronic spectra of Ni(II) complex exhibited absorption band at 22132 [cm.sup.-1] and assigned to be LMCT band and the d-d band suppressed by LMCT band. The position of these bands is consistent with octahedral geometry around the Ni(II) ion. The Ni(II) also showed paramagnetism, 3.91 BM [34].

3.6. EPR Spectra. The X-band EPR spectrum of the copper(II) complex was recorded in the solid state at room temperature and in DMSO solvents at liquid nitrogen temperature using the DPPH radical as the g marker (Figure 3). The complex has a well-resolved [g.sub.[parallel]] and broadened g regions and various Hamiltonian parameters have been calculated as [g.sub.[parallel]] = 2.339; [g.sub.[perpendicular to]] = 2.05; [A.sub.[parallel]] = 120 x [10.sup.4]. The trend [g.sub.[parallel]] > [g.sub.[perpendicular to]] observed in this complex indicates that the unpaired electron is most likely to be in the [MATHEMATICAL EXPRESSION NOT REPRODUCIBLE IN ASCII] orbital [35].

3.7. Cyclic Voltammetry. A cyclic voltammogram of Cu(II) complex presented in Table 4. Voltammogram (Figure 4) displays a reduction peak at Epc = -103.60 mV, with an associated oxidation peak at Epa = -214.77 mV at a scan rate of 50mV/s. The peak separation of this couple ([DELTA]Ep) is 0.77V and increases with scan rate, []/[I.sub.pc] = 1.03. Thus, the analyses of cyclic voltammetric responses at different scan rate gave the evidence for quasireversible one electron reduction. The most significant feature of the Cu(II) complex is the Cu(II)/Cu(I) couple. The ratio of cathodic-to-anodic peak height was less than one. However, the peak current increases with the increase of the square root of the scan rates. This establishes the electrode process as diffusion controlled [29]. In Co(II) complex shows a redox process corresponding to the Co(II)/Co(I) couple at Epa = 790 mV and the associated cathodic peak at Epc = 610 mV and the Ni(II) complex showed redox process corresponding to the Ni(II)/Ni(I) couple at Epa = 521 mV and the associated cathodic peak at Epc = 384 mV. These couples are also found to be quasi-reversible as the peak separation between the anodic and cathodic potentials. But the ratio between the anodic and cathodic currents suggests that the process is simple one-electron transfer, quasi-reversible process [36].

3.8. DNA Interaction Studies. DNA is a molecule of great biological significance and controls the structure and function of cells [36]. These important biological activities will be started via receiving a signal to DNA, which is often in the form of a regulatory protein binding to a particular region of the DNA molecule. The binding specificity and strength of this regulatory protein may be imitated by a small molecule; consequently DNA function can be artificially modulated, inhibited, or activated by binding this molecule instead of the protein [37]. Some studies show that binding can occur between the DNA base pairs (intercalation) [38, 39], while some results are indicative of their groove binding nature [40, 41]. DNA interaction studies have been carried out with the prepared complexes by using UV-visible, CD, and CV spectral techniques and DNA cleavage activity also has been studied by gel-electrophoresis which showed significant results.

3.8.1. DNA Binding-Absorption Spectra. The change of the UV spectra of complexes in the presence of different concentrations of DNA was studied. Hypochromism and red shift in the UV absorption spectra were observed upon addition of DNA increasing concentrations to the complexes solution in the absorption intensity region 275-280 nm and 344-346 nm. These effects are particularly pronounced for intercalators. In the case of groove binders wavelength shift is usually correlated with a conformational change on binding or complex formation [42]. In general, the extent of the hypochromism indicates the interaction binding strength and intrinsic binding constant, [K.sub.b] for complexes with CTDNA was determined according to (1) 43], where [DNA] is the concentration of DNA in base pairs. [[epsilon].sub.a] is the extinction coefficient for APM absorption band at a given DNA concentration, [[epsilon].sub.f] is extinction coefficient of free complexes, and [[epsilon].sub.b] is the extinction coefficient of complexes when fully bound to DNA (it is assumed when further addition of DNA does not change the absorbance).

In particular, [[epsilon].sub.f] was determined by a calibration curve of the isolated complexes in DMSO solution, following Beer's law. [[epsilon].sub.a] was determined as the ratio between the measured absorbance and the complex concentration. Plot of [DNA]/([[epsilon].sub.a] - [[epsilon].sub.f]) versus [DNA] gives a slope of 1/([[epsilon].sub.b] - [[epsilon].sub.f]) and a y-intercept equal to 1/[K.sub.b]([[epsilon].sub.b] - [[epsilon].sub.f]); [K.sub.b] is the ratio of the slope of the y-intercept (Figure 5 insert). The [K.sub.b] value was calculated to be 10.50 x 104, 5.88 x 104, and 6.81 x [10.sup.4] [M.sup.-1] (Table 5). The [K.sub.b] value obtained here is less than that of reported for classical intercalator (for ethidium bromide whose binding constants have been found to be in the order of [10.sup.6]-[10.sup.7] [M.sup.-1]) [44]. In comparing the intrinsic binding constant ([K.sub.b]) of Cu(II), Co(II), and Ni(II) complexes with DNA groove binders, as observed in the literature, we can deduce that this complex binds to CT-DNA via groove binding [45, 46].

3.8.2. DNA Binding-Cd Spectra. CD spectra is a useful technique in diagnosing changes in DNA morphology during drug-DNA interactions, since CD signals are quite sensitive to the mode of DNA interactions with small molecules [47]. In the case of CT-DNA interacting with metal complexes, the characteristic CD spectra showed two bands as a positive one at 275 nm due to the base stacking between the compounds and DNA bases and a negative band at 245 nm due to the right-handed helicity B form of DNA [48]. Observed changes in these CD signals of DNA are usually assigned to corresponding changes in its structure (Figure 6). The simple groove binding or electrostatic interaction between small molecules and DNA causes less or no perturbation on the base stacking and helicity bands, whereas a classical intercalation enhances both CD bands, stabilizing the CTDNA form B conformation, as observed for intercalative ligands [49]. Complexes Cu, Co, and Ni exhibited different binding constant values, determined in UV-visible experiments. Generally the DNA of A and B forms structures which have right-handed helix; however, the helical parameters are different in helix pitch, base pair tilt, and twist angle in degrees as 28, 20, and 33 (A form) and 24, -6, and 36 (B form), respectively. B form is the major form that is found in the cell (Watson and Crick 1953). However, after the complex addition to CT-DNA it was only verified as small perturbations in negative and positive bands of CD spectra for three complexes, as shown in Figure 6. Macias et al. [50] observed an increase in both positive and negative bands after incubating complexes with DNA, attributed to a typical intercalative mode, involving [pi] [right arrow] [[pi].sup.*] stacking and stabilization of the right-handed form of CT-DNA. Incubation of DNA with complexes shows little perturbation of the two bands, which is indicative of a nonintercalative interaction between complexes and DNA and offers another support to its groove binding nature [51].

3.8.3. DNA-Binding-Cyclic Voltammetry Study. Electrochemical investigations of metal-DNA interactions provide a useful complement to spectroscopic methods. Cyclic voltammogram of copper complex in the presence of CT-DNA in various concentrations is shown in Figure 7. CV data explored that Cu exhibited a pair of redox peaks for one electron transfer couple of Cu(II)/Cu(I) at the scan rate of 50mVs (curve). The ratio of (Ipa/Ipc) value of 0.5 and the peak to peak separation ([delta]Ep) of 0.44 V suggested the characteristic of the of the electrotransfer process and this was fairly common for Cu(II)/Cu(I) couple because of the reorganization of the coordination sphere. After interaction with CT-DNA, the value of [delta]Ep was decreased to 0.23 V suggesting that the reversibility of the electron-transfer process of the copper complex was changed better. Moreover, both the oxidation and the reduction peak potentials underwent positive shifts accompanied by the decreases of the redox peak currents. It has pointed out that the electrochemical potential of the small molecules would shift positively when it interacted into DNA double helix, and if it bounds to DNA by groove binding only takes place. So we thought that the greater affinity of Cu with CT-DNA is most likely caused by a specific binding mode [52]. The two quasireversible redox couple for Cu(II) complex and other complexes are irreversible redox couple for Co(II) and Ni(II).

3.8.4. DNA Cleavage Studies By Agarose Gel Electrophoresis. The ability of Cu(II), Co(II), and Ni(II) complexes to perform DNA cleavage was monitored by agarose gel electrophoresis with the pUC19 plasmid DNA. The experimental results were shown in Figure 8. Two clear bands were observed for the controls in which the three complexes were absent (lane 1). The relatively fast migration is the intact super coil form (Form II) and the slower moving migration is the open circular form (Form I), which was generated from super coiled when scission occurred on its one strand [53, 54]. The amount of Form II diminished gradually and partly converted to Form I and it is obvious that the complexes have more ability to cleave the super coiled plasmid DNA.

3.9. Cytotoxicity. The cytotoxicity assay for the new complexes was assessed using the method of MTT reduction. The market reference Mitomycin-C was used as a positive control. All the ligands and complexes were found to be cytotoxic to liver cancer cell line (HepG2). The I[C.sub.50] values (50% inhibition of cell growth for 48 h) for complexes Cu, Co, and Ni are 5 [micro]M, 10 [micro]M, 20 [micro]M, 25 [micro]M, and 30 [micro]M, respectively (Figure 9). The complexes exhibited higher cytotoxic effects on liver cancer cells with lower I[C.sub.50] values indicating their efficiency in killing the cancer cells even at low concentrations. The ligand did not show any significant activity up to 100 [micro]M. However, cytotoxic effectiveness of the compounds with an I[C.sub.50] of Cu and Ni complexes was higher than that of control. There are reports in the literature on the cytotoxic effects of the complexes with longer incubation time periods [55-57]. The longer incubation period may result in the development of cellular resistance for that particular complex. The complexes Cu and Ni is showed better activity than Co complex because the reduction potential of Cu(II) and Ni(II), almost in same order of magnitude; however the Co(II) is widely varied and mostly biocompatible in living system. Moreover, the I[C.sub.50] values of our complexes are comparable with the reported I[C.sub.50] values of standard anticancer drugs such as Mitomycin-C.

4. Conclusion

One of the most important goals of pharmacological research is the search for new molecular structures which exhibit effective antitumor activities. This has driven inorganic and organometallic chemists to look for new metal compounds with good activities, preferably against tumors that are responsible for high cancer mortality. In this study, new series of Schiff base (L) and its complexes Cu(II), Co(II), and Ni(II) showed octahedral geometry. The binding behaviors of the complexes toward CT-DNA were investigated by absorption spectroscopy, CD, and CV techniques. In conclusion competitive binding of complexes for DNA indicated that complexes could interact as a groove binder. It should be noted that the observed intrinsic binding constant (5.88-10.50 x [10.sup.4] [M.sup.-1]) is comparable to other groove binders as well and complexes Cu and Ni have stronger binding affinity than Co. The complexes bind to super coiled plasmid pUC19 DNA and display efficient hydrolytic cleavage and are a specific groove binder. The cytotoxic studies showed that the complexes Cu and Ni exhibit good cytotoxic activity against AGS cell line. Furthermore, these complexes have potential practical applications to formulate into an efficient drug against cancer.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


The authors sincerely acknowledge the financial support received from UGC-JRF (BSR), New Delhi. The authors express their sincere thanks to Dr. Kumaresan, Department of Genetics, School of Biological Sciences, MKU, for providing necessary research facilities.


[1] M. S. Karthikeyan, D. J. Prasad, B. Poojary, K. Subrahmanya Bhat, B. S. Holla, and N. S. Kumari, "Synthesis and biological activity of Schiff and Mannich bases bearing 2,4-dichloro-5fluorophenyl moiety," Bioorganic and Medicinal Chemistry, vol. 14, no. 22, pp. 7482-7489, 2006.

[2] A. Dandia, V. Sehgal, and P. Singh, "Synthesis of fluorine containing 2-aryl-3-pyrazolyl/pyranyl/isoxazolinyl-indole derivative as antifungal and antibacterial agents" Indian Journal of Chemistry B, vol. 32, pp. 1288-1291, 1993.

[3] K. Singh, M. S. Barwa, and P. Tyagi, "Synthesis, characterization and biological studies of Co(II), Ni(II), Cu(II) and Zn(II) complexes with bidentate Schiff bases derived by heterocyclic ketone" European Journal of Medicinal Chemistry, vol. 41, no. 1, pp. 147-153, 2006.

[4] O. M. Walsh, M. J. Meegan, R. M. Prendergast, and T. Al Nakib, "Synthesis of 3-acetoxyazetidin-2-ones and 3-hydroxyazetidin2-ones with antifungal and antibacterial activity," European Journal of Medicinal Chemistry, vol. 31, no. 12, pp. 989-1000, 1996.

[5] N. Raman, K. Pothiraj, and T. Baskaran, "DNA interaction, antimicrobial, electrochemical and spectroscopic studies of metal(II) complexes with tridentate heterocyclic Schiff base derived from 2,-methylacetoacetanilide," Journal of Molecular Structure, vol. 1000, no. 1-3, pp. 135-144, 2011.

[6] K. R. Surati and B. T. Thaker, "Synthesis, spectral, crystallography and thermal investigations of novel Schiff base complexes of manganese (III) derived from heterocyclic [beta]-diketone with aromatic and aliphatic diamine," Spectrochimica Acta A, vol. 75, no. 1, pp. 235-242, 2010.

[7] M. A. Ali, A. H. Mirza, H. J. H. A. Bakar, and P. V. Bernhardt, "Preparation and structural characterization of nickel(II), cobalt(II), zinc(II) and tin(IV) complexes of the isatin Schiff bases of S-methyl and S-benzyldithiocarbazates," Polyhedron, vol. 30, no. 4, pp. 556-564, 2011.

[8] G. Cerchiaro, G. A. Micke, M. F. M. Tavares, and A. M. da Costa Ferreira, "Kinetic studies of carbohydrate oxidation catalyzed by novel isatin-Schiff base copper(II) complexes," Journal of Molecular Catalysis A, vol. 221, no. 1-2, pp. 29-39, 2004.

[9] Z. H. Chohan, H. Pervez, A. Rauf, K. M. Khan, and C. T. Supuran, "Isatin-derived antibacterial and antifungal compounds and their transition metal complexes," Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 19, no. 5, pp. 417-423, 2004.

[10] V. Arjunan, I. Saravanan, P. Ravindran, and S. Mohan, "Structural, vibrational and DFT studies on 2-chloro-1H-isoindole-1,3(2H)-dione and 2-methyl-1H-isoindole-1,3(2H)-dione," Spectrochimica Acta A, vol. 74, no. 3, pp. 642-649, 2009.

[11] V. Pawar, D. Lokwani, S. Bhandari et al., "Design of potential reverse transcriptase inhibitor containing Isatin nucleus using molecular modeling studies," Bioorganic and Medicinal Chemistry, vol. 18, no. 9, pp. 3198-3211, 2010.

[12] C. Metcalfe and J. A. Thomas, "Kinetically inert transition metal complexes that reversibly bind to DNA," Chemical Society Reviews, vol. 32, no. 4, pp. 215-224, 2003.

[13] K. E. Erkkila, D. T. Odom, and J. K. Barton, "Recognition and reaction of metallointercalators with DNA," Chemical Reviews, vol. 99, no. 9, pp. 2777-2795,1999.

[14] V.Uma, V.G. Vaidyanathan, and B. U. Nair, "Synthesis, structure, and DNA binding studies of copper(II) complexes of terpyridine derivatives," Bulletin of the Chemical Society of Japan, vol. 78, no. 5, pp. 845-850, 2005.

[15] W. Szczepanik, J. Ciesiolka, J. Wrzesrnski, J. Skala, and M. Jezowska-Bojczuk, "Interaction of aminoglycosides and their copper(II) complexes with nucleic acids: implication to the toxicity of these drugs," Dalton Transactions, no. 8, pp. 1488-1494, 2003.

[16] Q.-L. Li, J. Huang, Q. Wang et al., "Monometallic complexes of 1,4,7,10-tetraazacyclododecane containing an imidazolium side: synthesis, characterization, and their interaction with plasmid DNA," Bioorganic and Medicinal Chemistry, vol. 14, no. 12, pp. 4151-4157, 2006.

[17] P K. Dubey, S. Srinivas Rao, and V Aparna, "Synthesis of some novel 3-(2-chloro-3-quinolyl)-5-phenyl [1,3] thiazolo [2,3-c] [1,2,4] triazoles," Heterocyclic Communications, vol. 9, no. 3, pp. 281-286, 2003.

[18] R. Gomathi, A. Ramu, and A. Murugan, "Synthesis, spectral characterization of N-benzyl isatin schiff base Cu(II), Co(II) and Ni(II) complexes and their effect on cancer cell lines,," International Journal of Innovative Research in Science, Engineering and Technology, vol. 2, no. 10, pp. 5156-5166, 2013.

[19] R. Gomathi and A. Ramu, "Synthesis, DNA binding, cleavage, antibacterial and cytotoxic activity of Novel Schiff base Co(II) Complexes of substituted isatin," International Journal of Advanced Research, vol. 1, no. 8, pp. 556-567, 2013.

[20] R. Hettich and H.-J. Schneider, "Cobalt(III) polyamine complexes as catalysts for the hydrolysis of phosphate esters and of DNA. A measurable 10 million-fold rate increase," Journal of the American Chemical Society, vol. 119, no. 24, pp. 5638-5647, 1997

[21] C.-C. Cheng, Y.-N. Kuo, K.-S. Chuang, C.-F. Luo, and W. J. Wang, "A new CoII complex as a bulge-specific probe for DNA," Angewandte Chemie (International Edition), vol. 38, no. 9, pp. 1255-1257, 1999.

[22] R. Gomathi and A. Ramu, "Synthesis, characterization of novel Cu(II) complexes of isatin derivatives as potential cytotoxicity, DNA binding, cleavage and antibacterial agents," International Journal of Innovative Research in Science Engineering and Technology, vol. 2, no. 9, pp. 4852-4486, 2013.

[23] A. Wolfe, G. H. Shimer Jr., and T. Meehan, "Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denatured DNA," Biochemistry, vol. 26, no. 20, pp. 6392-6396, 1987.

[24] F. A. Beckford, M. Shaloski Jr., G. Leblanc et al., "Microwave synthesis of mixed ligand diimine-thiosemicarbazone complexes of ruthenium(II): biophysical reactivity and cytotoxicity," Dalton Transactions, no. 48, pp. 10757-10764, 2009.

[25] S. P Hiremath, B. H. M. Mruthyunjayaswamy, and M. G. Purohit, "Synthesis of substituted 2-aminoindolees and 2(2,-Phenyl-1',3',4'-oxadiazolyl)aminoindoles," Indian Journal of Chemistry B, vol. 16, pp. 789-792, 1978.

[26] A. D. Kulkarni, S. A. Patil, and P. S. Badami, "Electrochemical properties of some transition metal complexes: synthesis, characterization and In-vitro antimicrobial studies of Co(II), Ni(II), Cu(II), Mn(II) and Fe(III) complexes," International Journal of Electrochemical Science, vol. 4, no. 5, pp. 717-729, 2009.

[27] D.-D. Li, J.-L. Tian, W. Gu, X. Liu, and S.-P Yan, "Synthesis, X-ray crystal structures, DNA binding and nuclease activities of two novel 1,2,4-triazole-based CuII complexes," European Journal of Inorganic Chemistry, no. 33, pp. 5036-5045, 2009.

[28] M. P Fitzsimons and J. K. Barton, "Design of a synthetic nuclease: DNA hydrolysis by a zinc-binding peptide tethered to a rhodium intercalator," Journal of the American Chemical Society, vol. 119, no. 14, pp. 3379-3380, 1997

[29] F. Arjmand, S. Parveen, M. Afzal, L. Toupet, and T. Ben Hadda, "Molecular drug design, synthesis and crystal structure determination of CuII-SnIV heterobimetallic core: DNA binding and cleavage studies," European Journal of Medicinal Chemistry, vol. 49, pp. 141-150, 2012.

[30] P Guerriero, S. Tamburini, and P A. Vigato, "From mononuclear to polynuclear macrocyclic or macroacyclic complexes," Coordination Chemistry Reviews, vol. 139, pp. 17-243, 1995.

[31] S. Budagumpi, G. S. Kurdekar, G. S. Hegde, N. H. Bevinahalli, and V. K. Revankar, "Versatility in the coordination behavior of a hexatopic compartmental Schiff-base ligand in the architecture of binuclear transition metal(II) complexes," Journal of Coordination Chemistry, vol. 63, no. 8, pp. 1430-1439, 2010.

[32] S. Shashidhar, K. Shivakumar, P. V. Reddy, and M. B. Halli, "Synthesis and spectroscopic characterization of metal complexes with naphthofuran-2-carbohydrazide Schiff's base," Journal of Coordination Chemistry, vol. 60, no. 3, pp. 243-256, 2007.

[33] H. Liu, H. Wang, F. Gao, D. Niu, and Z. Lu, "Self-assembly of copper(II) complexes with substituted aroylhydrazones and monodentate N-heterocycles: synthesis, structure and properties," Journal of Coordination Chemistry, vol. 60, no. 24, pp. 2671-2678, 2007.

[34] D. P. Singh, R. Kumar, V. Malik, and P. Tyagi, "Synthesis and characterization of complexes of Co(II), Ni(II), Cu(II), Zn(II), and Cd(II) with macrocycle 3,4,11,12-tetraoxo-1,2,5,6,9,10,13,14-octaaza-cyclohexadeca-6,8,14,16-tetraene and their biological screening," Transition Metal Chemistry, vol. 32, no. 8, pp. 1051-1055, 2007

[35] V. C. da Silveira, H. Benezra, J. S. Luz, R. C. Georg, C. C. Oliveira, and A. M. D. C. Ferreira, "Binding of oxindole-Schiff base copper(II) complexes to DNA and its modulation by the ligand," Journal of Inorganic Biochemistry, vol. 105, no. 12, pp. 1692-1703, 2011.

[36] Y. Ni, D. Lin, and S. Kokot, "Synchronous fluorescence, UV-visible spectrophotometric, and voltammetric studies of the competitive interaction of bis(1,10-phenanthroline)copper(II) complex and neutral red with DNA," Analytical Biochemistry, vol. 352, no. 2, pp. 231-242, 2006.

[37] B. W. Rossister and J. F. Hamilton, Physical Method of Chemisty, John Wiley & Sons, New York, NY, USA, 2nd edition, 1985.

[38] F.-Y. Wu, F.-Y. Xie, Y.-M. Wu, and J.-I. Hong, "Interaction of a new fluorescent probe with DNA and its use in determination of DNA," Journal of Fluorescence, vol. 18, no. 1, pp. 175-181, 2008.

[39] P. B. Dervan, R. M. Doss, and M. A. Marques, "Programmable DNA binding oligomers for control of transcription," Current Medicinal Chemistry, vol. 5, no. 4, pp. 373-387, 2005.

[40] S. Kashanian and J. Ezzati Nazhad Dolatabadi, "In vitro study ofcalfthymus DNA interaction with butylated hydroxyanisole," DNA and Cell Biology, vol. 28, no. 10, pp. 535-540, 2009.

[41] S. Kashanian, M. M. Khodaei, H. Roshanfekr, N. Shahabadi, A. Rezvani, and G. Mansouri, "DNA binding, DNA cleavage, and cytotoxicity studies of two new copper (II) complexes," DNA and Cell Biology, vol. 30, no. 5, pp. 287-296, 2011.

[42] S. Kashanian and S. H. Zeidali, "DNA binding studies of tartrazine food additive," DNA and Cell Biology, vol. 30, no. 7, pp. 499-505, 2011.

[43] S. Kashanian, Z. Shariati, H. Roshanfekr, and S. Ghobadi, "DNA binding studies of 3, 5, 6-trichloro-2-pyridinol pesticide metabolite," DNA Cell Biology, vol. 31, pp. 1314-1348, 2012.

[44] R. Bera, B. K. Sahoo, K. S. Ghosh, and S. Dasgupta, "Studies on the interaction of isoxazolcurcumin with calf thymus DNA," International Journal of Biological Macromolecules, vol. 42, no. 1, pp. 14-21, 2008.

[45] R. Liu, J. Yang, and X. Wu, "Study of the interaction between nucleic acid and oxytetracycline-[Eu.sup.3+] and its analytical application," Journal of Luminescence, vol. 96, no. 2-4, pp. 201-209, 2002.

[46] M. J. Waring, "Complex formation between ethidium bromide and nucleic acids," Journal of Molecular Biology, vol. 13, no. 1, pp. 269-282, 1965.

[47] V. G. Vaidyanathan and B. U. Nair, "Photooxidation of DNA by a cobalt(II) tridentate complex," Journal of Inorganic Biochemistry, vol. 94, no. 1-2, pp. 121-126, 2003.

[48] Z.-H. Xu, F.-J. Chen, P.-X. Xi, X.-H. Liu, and Z.-Z. Zeng, "Synthesis, characterization, and DNA-binding properties of the cobalt(II) and nickel(II) complexes with salicylaldehyde 2-phenylquinoline-4-carboylhydrazone," Journal of Photochemistry and Photobiology A, vol. 196, no. 1, pp. 77-83, 2008.

[49] L. Milne, P. Nicotera, S. Orrenius, and M. J. Burkitt, "Effects of glutathione and chelating agents on copper-mediated DNA oxidation: pro-oxidant and antioxidant properties of glutathione," Archives of Biochemistry and Biophysics, vol. 304, no. 1, pp. 102-109, 1993.

[50] B. Macias, M. V. Villa, B. Gomez et al., "DNA interaction of new copper(II) complexes with new sulfoamides as ligands," Journal of Inorganic Biochemistry, vol. 101, pp. 441-451, 2007

[51] P. Uma Maheswari and M. Palaniandavar, "DNA binding and cleavage properties of certain tetrammine ruthenium(II) complexes of modified 1,10-phenanthrolines--effect of hydrogenbonding on DNA-binding affinity," Journal of Inorganic Biochemistry, vol. 98, no. 2, pp. 219-230, 2004.

[52] Z. Zhang, Y. Yang, F. Liu, X. Qian, and Q. Xu, "Study on the interaction between 4-(2-diethylamino-ethylamino)-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile and DNA by molecular spectra," International Journal of Biological Macromolecules, vol. 38, no. 1, pp. 59-64, 2006.

[53] T. Hirohama, Y. Kuranuki, E. Ebina et al., "Copper(II) complexes of 1,10-phenanthroline-derived ligands: studies on DNA binding properties and nuclease activity," Journal of Inorganic Biochemistry, vol. 99, no. 5, pp. 1205-1219, 2005.

[54] A. K. Patra, S. Dhar, M. Nethaji, and A. R. Chakravarty, "Metal-assisted red light-induced DNA cleavage by ternary Lmethionine copper(II) complexes of planar heterocyclic bases," Dalton Transactions, no. 5, pp. 896-902, 2005.

[55] E. Gao, Y. Sun, Q. Liu, and L. Duan, "An anticancer metallobenzylmalonate: crystal structure and anticancer activity of a palladium complex of 2,2;-bipyridine and benzylmalonate," Journal of Coordination Chemistry, vol. 59, no. 11, pp. 1295-1300, 2006.

[56] M. Ferrari, M. C. Fornasiero, and A. M. Isetta, "MTT colorimetric assay for testing macrophage cytotoxic activity in vitro," Journal of Immunological Methods, vol. 131, no. 2, pp. 165-172, 1990.

[57] N. A. Rey, A. Neves, P. P. Silva et al., "A synthetic dinuclear copper(II) hydrolase and its potential as antitumoral: cytotoxicity, cellular uptake, and DNA cleavage," Journal of Inorganic Biochemistry, vol. 103, no. 10, pp. 1323-1330, 2009.

Ramadoss Gomathi, (1) Andy Ramu, (1) Athiappan Murugan (2)

(1) Department of Inorganic Chemistry, School of Chemistry, Madurai Kamaraj University, Madurai, Tamil Nadu 625 021, India

(2) Department of Microbiology, Periyar University, Salem, Tamil Nadu 636011, India

Correspondence should be addressed to Andy Ramu;

TABLE 1: Composition and physical characteristics of ligand and their

Ligand/     Molecular              Color
complexes   formula

L           [C.sub.20][H.sub.14]   Crystalline
            [N.sub.4][O.sub.2]     yellow
L-Cu        [C.sub.41][H.sub.31]   Green
L-Co        [C.sub.41][H.sub.31]   Dark green
L-Ni        [C.sub.41][H.sub.31]   Yellow

Ligand/              Found (calculated) %
complexes   M        C         H        N

L                    70.01     3.97     16.52
                     (70.14)   (4.12)   (16.37)
L-Cu        7.51     59.37     3.71     13.11
            (762)    (59.03)   (3.75)   (13.43)

L-Co        6.58     59.32     3.63     13.47
            (710)    (59.36)   (3.77)   (13.51)

L-Ni        7.31     59.35     3.68     13.56
            (7.08)   (59.38)   (3.77)   (13.51)

Ligand/     M.P            Yield   [OMEGA]
complexes   ([degrees]C)   (%)     ([Ohm.sup.-1]

L           180            95      --

L-Cu        >300           83      22.000

L-Co        >285           80      34.40

L-Ni        >285           80      28.50

TABLE 2: Infrared spectral data for the free ligand and their
complexes in KBr disc ([cm.sup.-1]).

Compounds   C=N       C=O        C=O           NH     M-O   M-N
            (imine)   (isatin)   (isoniazid)

L           1602      1695       1685          3269   --    --
L-Cu        1612      1691       1673          3265   601   453
L-Co        1612      1693       1676          3263   572   447
L-Ni        1610      1693       1674          3268   574   449

TABLE 3: Electronic spectral parameters and magnetic moment with
suggested geometry of the complexes.

Compound   [pi] [right arrow]   n [right arrow]     LMCT
           [[pi].sup.*]         [[pi].sup.*]
           ([cm.sup.-1])        ([cm.sup.-1])

L          36764                29239
L-Cu       35971                29069               22026

L-Co       36231                29068               --

L-Ni       36496                29069               22132

Compound   d-d band      Assignment           Suggested

L-Cu       12345         [sup.2][B.sub.1g]    Distorted
                         [right arrow]        octahedral
L-Co       16339,14836   [sup.4][T.sub.1g]    Octahedral
                         (F) [right arrow]
L-Ni       --             [sup.3][A.sub.2g]    Octahedral
                         [right arrow]

Compound   [[mu].sub.eff]

L-Cu       4.52

L-Co       4.13

L-Ni       3.91

TABLE 4: Electrochemical parameters for Cu(II), Co(II), and Ni(II)

Compound   Redox couple   Epa    Epc    Aep    Ipa/Ipc
                          (mV)   (mV)   (mV)

L-Cu       Cu(II)/Cu(I)   -214   -103   111    1.03
L-Co       Co(II)/Co(I)   790    610    180    0.82
L-Ni       Ni(II)/Ni(I)   521    384    137    0.91

TABLE 5: Absorption properties of metal (II) complexes with CT-

Complexes   [[lambda].   [delta]    Hypochromicity   [K.sub.b]
            sub.max]     [lambda]   (%)              ([M.sup.-1])
            (nm)         (nm)

L-Cu(II)    275, 345     3          59.05, 65.45     10.50
L-Co(II)    280, 346     5          3753, 42.18      5.88
L-Ni(II)    275, 344     2          37.53, 58.48     6.81
COPYRIGHT 2014 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Gomathi, Ramadoss; Ramu, Andy; Murugan, Athiappan
Publication:Bioinorganic Chemistry and Applications
Article Type:Report
Date:Jan 1, 2014
Previous Article:Synthesis, spectral characterization, and antiproliferative studies of mixed ligand titanium complexes of adamantylamine.
Next Article:Preparation and characterization of Di-, Tri-, and tetranuclear Schiff base complexes derived from diamines and 3,4-dihydroxybenzaldehyde.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |